The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179, 7684 -7691
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, J.
Right arrow Articles by Hancock, R. E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, J.
Right arrow Articles by Hancock, R. E. W.

Host Defense Peptide LL-37, in Synergy with Inflammatory Mediator IL-1β, Augments Immune Responses by Multiple Pathways1

Jie Yu*, Neeloffer Mookherjee*, Kathleen Wee*, Dawn M. E. Bowdish{dagger}, Jelena Pistolic*, Yuexin Li*, Linda Rehaume* and Robert E. W. Hancock2,*

* Department of Microbiology and Immunology, Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, British Columbia, Canada; and {dagger} Sir William Dunn School of Pathology, University of Oxford, United Kingdom

The human cathelicidin LL-37 is a cationic host defense peptide and serves as an important component of innate immunity. It has been demonstrated to be a multifunctional modulator of innate immune responses, although the mechanism(s) underlying this have not been well characterized. In this study, it was demonstrated that LL-37 synergistically enhanced the IL-1β-induced production of cytokines (IL-6, IL-10) and chemokines such as macrophage chemoattractant proteins (MCP-1, MCP-3) in human PBMC, indicating a role in enhancing certain innate immune responses. Similarly, LL-37 synergistically enhanced chemokine production in the presence of GM-CSF, but IFN-{gamma}, IL-4, or IL-12 addition led to antagonism, indicating that the role of LL-37 in reinforcing specific immune responses is selective and restricted to particular endogenous immune mediators. The inhibition of G protein-coupled receptors and PI3K substantially suppressed the ability of IL-1β and LL-37 to synergistically enhance the production of chemokine MCP-3. Consistent with this, the combination of IL-1β and LL-37 enhanced the activation/phosphorylation of kinase Akt and the transcription factor CREB. The role of transcription factor NF-{kappa}B was revealed through the demonstration of enhanced phosphorylation of I{kappa}B{alpha} and the consequent nuclear translocation of NF-{kappa}B subunits p50 and p65, as well as the antagonistic effects of an inhibitor of I{kappa}B{alpha} phosphorylation. These results together indicate that the human host defense peptide LL-37 can work in synergy with the endogenous inflammatory mediator IL-1β to enhance the induction of specific inflammatory effectors by a complex mechanism involving multiple pathways, thus reinforcing certain innate immune responses.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Genome British Columbia and Genome Prairie for the Pathogenomics of Innate Immunity Research Program and from the Foundation for the National Institutes of Health and Canadian Institutes for Health Research through the Grand Challenges in Global Health Initiative. D.M.E.B. was supported by a Canadian Institute for Health Research Fellowship. R.E.W.H. is the recipient of a Canada Research Chair. K.W. is a recipient of a Translational Research in Infectious Diseases undergraduate co-op studentship.

2 Address correspondence and reprint requests to Dr. Robert E. W. Hancock, Department of Microbiology and Immunology, Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, British Columbia, Canada. E-mail address: bob{at}cmdr.ubc.ca

3 Abbreviations used in this paper: GPCR, G protein-coupled receptor; PK, protein kinase.




This article has been cited by other articles:


Home page
J. Immunol.Home page
H.-M. Lee, J.-M. Yuk, D.-M. Shin, C.-S. Yang, K.-K. Kim, D.-K. Choi, Z.-L. Liang, J.-M. Kim, B. H. Jeon, C. D. Kim, et al.
Apurinic/Apyrimidinic Endonuclease 1 Is a Key Modulator of Keratinocyte Inflammatory Responses
J. Immunol., November 15, 2009; 183(10): 6839 - 6848.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Nijnik, J. Pistolic, A. Wyatt, S. Tam, and R. E. W. Hancock
Human Cathelicidin Peptide LL-37 Modulates the Effects of IFN-{gamma} on APCs
J. Immunol., November 1, 2009; 183(9): 5788 - 5798.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-S. Yang, D.-M. Shin, K.-H. Kim, Z.-W. Lee, C.-H. Lee, S. G. Park, Y. S. Bae, and E.-K. Jo
NADPH Oxidase 2 Interaction with TLR2 Is Required for Efficient Innate Immune Responses to Mycobacteria via Cathelicidin Expression
J. Immunol., March 15, 2009; 182(6): 3696 - 3705.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.